The usefulness of tacrolimus in the topical treatment of autoimmune bullous diseases

Joanna Narbutt; Marcin Pełka; Anna Zalewska; Anna Sysa-Jędrzejowska

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/2005
vol. 22

Send email

Copy url:

abstract:

The usefulness of tacrolimus in the topical treatment of autoimmune bullous diseases

Joanna Narbutt

,

Marcin Pełka

,

Anna Zalewska

,

Anna Sysa-Jędrzejowska

PDiA 2005; XXII, 3: 129–132

Online publish date: 2005/06/23

View full text Get citation

Autoimmune bullous diseases are characterized by the presence of bullous lesions and erosions located on the skin and/or mucous membranes. Treatment of those diseases, including systemic administration of immunosuppressants, is associated with adverse effects. Topical application of glicocorticosteroids and antiseptic and agents is considered only as an adjuvant therapy. In the paper we present two cases of autoimmune bullous diseases –pemphigus vulgaris and pemphigoid, treated with systemic therapy and topical tacrolimus (0.1% ointment). This kind of treatment resulted in rapid and long-lasting clinical remission. Based on these observations, we conclude that topical application of tacrolimus is highly effective adsjuvant agent in the treatment of autoimmune bullous diseases.

keywords:

The usefulness of tacrolimus in the topical treatment of autoimmune bullous diseases

Joanna Narbutt , Marcin Pełka , Anna Zalewska , Anna Sysa-Jędrzejowska

tacrolimus, pemphigus vulgaris, pemphigoid, treatment

Joanna Narbutt

,

Marcin Pełka

,

Anna Zalewska

,

Anna Sysa-Jędrzejowska